首页|期刊导航|沈阳农业大学学报|巴戟散水提物协同调控凋亡通路促进梅花鹿耳缘成纤维细胞增殖

巴戟散水提物协同调控凋亡通路促进梅花鹿耳缘成纤维细胞增殖OA

Bajisan Water Extract Synergistically Regulating Apoptotic Pathways to Promote the Proliferation of Ear Margin Fibroblasts in Cervus nippon

中文摘要英文摘要

[目的]研究巴戟散水提物对梅花鹿耳缘成纤维细胞增殖作用及其调控凋亡效应.[方法]选取成年梅花鹿24头,随机分为空白对照组和给药组.给药组连续30 d每日饲喂含巴戟散水提物的日粮(500 mg·kg-1).给药结束后采集耳缘皮肤组织并经组织块贴壁法分离原代成纤维细胞.通过细胞形态学观察、MTT法检测细胞活力、绘制生长曲线以及qPCR技术,分析巴戟散水提物对细胞增殖速度及凋亡相关基因表达的影响.[结果]两组细胞均呈现典型成纤维细胞形态学特征,细胞生长曲线呈"S"形.给药组增殖速率显著高于空白对照组(P<0.05),其细胞密度峰值出现于接种后第4天,早于空白对照组(第6 天).MTT检测显示,在P2、P3代细胞培养72 h后,给药组细胞增殖速度分别为空白对照组的1.97倍和1.68倍(P<0.05).qPCR检测显示,与对照组相比,给药组显著上调抗凋亡基因Bcl-2的mRNA相对表达量(P<0.01),下调促凋亡基因Bax的mRNA相对表达量(P<0.05),使Bcl-2/Bax比值显著升高(P<0.05).同时,给药组极显著抑制内源性(线粒体)凋亡通路关键基因Caspase-9和Apaf1(P<0.01),以及外源性(死亡受体)凋亡通路关键基因Fas、TNFRSF1A、DR5和凋亡执行分子Caspase-3、Caspase-8(P<0.05)的mRNA相对表达量.[结论]巴戟散水提物能够促进梅花鹿耳缘皮肤成纤维细胞增殖,并显著抑制细胞凋亡.其作用机制涉及协同调控内源性和外源性凋亡通路,表现为上调抗凋亡基因表达,下调促凋亡基因表达,并抑制Caspase级联反应,为濒危鹿科动物种质资源库构建提供技术支持,也为中药复方在细胞生物学领域的作用机制研究提供新视角.

[Objective]This study investigated the effect of spray-dried powder of Bajisan on the proliferation of auricular marginal skin fibroblasts in Cervus nippon and its regulatory effect on the expression of apoptosis-related genes.[Method]Twenty-four adult Cervus nippon were randomly divided into control group and treatment group.The treatment group(500 mg·kg-1)was fed a diet containing Water Extract of Bajisan daily for one month.Auricular marginal skin tissue was collected after treatment completion.Primary fibroblasts were isolated and cultured using the explant attachment method.Effect of Water Extract of Bajisan on cell proliferation activity and apoptosis-related gene expression were analyzed through cell morphology observation,MTT assay for cell viability,growth curve plotting,and qPCR technology.[Result]The results showed that cells from both groups exhibited typical fibroblast morphological characteristics.The cell growth curves exhibited an'S'shape.The proliferation rate of the treatment group was significantly higher than that of the control group(P<0.05).The peak cell density in the treatment group occurred on day 4 post-seeding,earlier than in the control group(day 6).MTT assay revealed that at 72 h post-seeding for P2 and P3 generation cells,the proliferation activity in the treatment group was 1.97 times and 1.68 times higher,respectively,compared to the control group(P<0.05).qPCR analysis demonstrated that,compared to the control group,the treatment group significantly upregulated the relative mRNA expression level of the anti-apoptotic gene Bcl-2(P<0.01)and downregulated the relative mRNA expression level of the pro-apoptotic gene Bax(P<0.05),resulting in a significantly increased Bcl-2/Bax ratio(P<0.05).Furthermore,the treatment group significantly inhibited the relative mRNA expression levels of key genes in the intrinsic(mitochondrial)apoptotic pathway(Caspase-9 and Apaf1;P<0.01),as well as key genes in the extrinsic(death receptor)apoptotic pathway(Fas,TNFRSF1A and DR5)and the apoptosis execution molecules(Caspase-3 and Caspase-8;P<0.05).These results indicate that Water Extract of Bajisan can promote the proliferation of auricular marginal skin fibroblasts in Cervus nipponand significantly inhibit cell apoptosis.Its mechanism involves the synergistic regulation of both intrinsic and extrinsic apoptotic pathways,manifested by upregulating anti-apoptotic gene expression,downregulating pro-apoptotic gene expression,and inhibiting the caspase cascade reaction.[Conclusion]This research provides technical support for the construction of germplasm resource banks of endangered deer species and also offers a new perspective for the study of the mechanism of action of traditional Chinese medicine compound prescriptions in the field of cell biology.

张靖;陈丽红;杨月春;王士勇

贵州中医药大学 中兽药产业化创新应用中心,贵阳 550025贵州中医药大学 中兽药产业化创新应用中心,贵阳 550025贵州中医药大学 中兽药产业化创新应用中心,贵阳 550025贵州中医药大学 中兽药产业化创新应用中心,贵阳 550025

农业科技

巴戟散水提物梅花鹿耳缘皮肤成纤维细胞凋亡通路

Bajisan water extractCervus nipponauricular marginal skin fibroblastapoptotic pathways

《沈阳农业大学学报》 2026 (3)

98-106,9

贵州省科技计划项目(黔科合支撑[2022]一般131号)贵州中医药大学2020年博士启动基金(贵中医博士启动[2020]02号和55号)

10.3969/j.issn.1000-1700.2026.03.010

评论